Table 1 Patient Characteristics
Characteristic | Pharmacist Visit N (%) | No Pharmacist Visit N (%) | Standardized Differences |
|---|---|---|---|
Count | 5749 | 5749 | Â |
Age | |||
  < 35 | 56 (1.1) | 56 (0.97) | −0.02 |
 35–44 | 346 (6.02) | 426 (7.4) | −0.06 |
 45–54 | 1138 (19.8) | 1339 (23.3) | −0.09 |
 55–64 | 2537 (44.1) | 2453 (42.7) | 0.03 |
 65–74 | 1116 (19.4) | 982 (17.1) | 0.06 |
 75–84 | 488 (8.5) | 423 (7.4) | 0.04 |
 85+ | 68 (1.2) | 61 (1.1) | 0.01 |
Race | |||
 White | 4374 (76.1) | 4468 (77.7) | −0.04 |
 African American | 1182 (20.6) | 1077 (18.7) | 0.05 |
 Asian | 60 (1.0) | 56 (1.0) | 0.01 |
 Native American | 54 (0.9) | 68 (1.2) | −0.02 |
 Hawaiian/Pacific Islander | 79 (1.4) | 80 (1.4) | −0.002 |
Geographic Region | |||
 Northeast | 475 (8.3) | 519 (9) | −0.03 |
 Midwest | 1484 (25.8) | 1372 (23.9) | 0.05 |
 South | 2479 (43.1) | 2565 (44.6) | −0.03 |
 West | 1311 (22.8) | 1293 (22.5) | 0.01 |
 Male | 5535 (96.3) | 5526 (96.2) | 0.003 |
Initial Medication | |||
 Metformin | 3677 (63.9) | 3610 (62.8) | 0.02 |
 Sulfonylurea | 1903 (33.1) | 1950 (33.9) | −0.02 |
 Thiazolidinedione | 74 (1.3) | 87 (1.5) | −0.02 |
 All other OADs | 95 (1.7) | 102 (1.8) | −0.01 |
 Charlson Comobidity Indexa | 0.5 (0.68) | 0.5 (0.65) | −0.05 |
Previous Event/Condition | |||
 Cerebrovascular Disease | 354 (6.2) | 337 (5.9) | 0.01 |
 Myocardial Infarction | 302 (5.3) | 259 (4.5) | 0.03 |
 Congestive Heart Failure | 313 (5.4) | 283 (4.9) | 0.02 |
 Chronic Pulmonary Obstructive Disease | 1237 (21.5) | 1189 (20.7) | 0.02 |
 Peripheral Artery Disease | 261 (4.5) | 284 (4.9) | −0.02 |
 Body Mass Indexa | 33.5 (6.0) | 33.4 (5.8) | 0.01 |
 Baseline Hemoglobin A1C, %a | 8.6 (1.6) | 8.7 (1.6) | −0.04 |